Australian Clinical Labs Limited (ASX: ACL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Australian Clinical Labs Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Australian Clinical Labs Limited (ASX: ACL)
Latest News
Healthcare Shares
What's going on with the Australian Clinical Labs (ASX:ACL) share price lately?
Broker Notes
Brokers name 3 ASX shares to buy today
Share Gainers
Why Australian Clinical Labs, Magellan, Sandfire, and Telix shares are rising
Healthcare Shares
Why the Australian Clinical Labs (ASX:ACL) share price is up 10% to a record high
Share Gainers
Why Australian Clinical Labs, Humm, Neometals, and Viva Energy are rising
Small Cap Shares
Analysts are tipping huge gains for these small cap ASX shares
Healthcare Shares
2 ASX healthcare shares rated as buys
Broker Notes
Experts love these 2 ASX shares punching above their weight
Broker Notes
Brokers name 2 ASX healthcare shares to buy
Healthcare Shares
Australian Clinical Labs (ASX:ACL) share price on watch following profit upgrade
Share Gainers
Australian Clinical Labs (ASX:ACL) share price soars 9% after smashing profit forecast
Share Market News
2 ASX shares liked by this top fund manager
Frequently Asked Questions
-
Yes, Australian Clinical Labs has historically paid two fully franked shareholder dividends a year.
-
Australian Clinical Labs generally pays its shareholder dividends in April and September.
-
Australian Clinical Labs Ltd listed on the ASX on 14 May 2021.
ACL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Australian Clinical Labs Limited
Australian Clinical Labs Ltd (ASX: ACL) is a leading provider of pathology services in Australia. The company's 75 laboratories perform more than 12 million episodes annually with a network of more than 1,300 collection centres in every Australian state and territory except Tasmania. The company is also among the largest private hospital pathology businesses in the country, providing services to more than 90 private and public hospitals.
Its services include all routine pathology tests, advanced pathology, pregnancy screening, non-invasive prenatal testing, chemical pathology, haematology, histopathology, immunology, serology and microbiology, and commercial drug and alcohol testing.
In ACL's established regions of Western Australia, Victoria, New South Wales, Queensland, South Australia, and the Northern Territory, the company has an equivalent market position in community pathology to its rivals Sonic Healthcare Ltd (ASX: SHL) and Healius Ltd (ASX: HLS). The company says it also has a growing presence in the Australian Capital Territory.
